Skip to main content
. 2014 Jul 11;12:26. doi: 10.1186/1546-0096-12-26

Table 1.

Laboratory values

Hospital Day CRP, mg/dl (normal <10) ESR, mm/hr (normal <15) Hb, g/dl (normal 12.5-19) WBC × 10 3/ mm 3 (normal 6–18) Neutrophil (%) (normal 19–45) PLTs × 10 3/ mm 3 (normal 140–400) AST, U/l (normal 15–60) ALT, U/l (normal 10–40) Triglyceride, mg/dl (normal <149) Fibrinogen, mg/dl (range 220–450) Ferritin, ng/ml (normal 50–200) GGT, U/l (normal 8–80) Other labs and important events related to clinical course:
1
 
 
9.6
14.3
57
229
 
 
 
 
 
 
Serum sodium 130 mEq/L Total bilirubin 3.5 mg/dL
3
133.4
40
6.9
12.12
59
32
25
18
 
 
 
138
Serum sodium 131 mEq/L Hypoalbuminemia of 1.8 g/dL (reference range: 3.4-5.4 g/dL) IVIG dose #1
4
 
 
10.1
16.8
 
121
24
19
82
 
801
 
IVIG dose #2/Transfusion
6
191.6
24
9.9
27.5
 
66
22
17
 
239
255
 
IVIG dose#3 Methylprednisolone 30 mg/kg × 3 days Flow cytometry
7
234.1
113
8.2
16.6
 
52
 
 
 
273
207
 
Anakinra started
(3 mg/kg BID) (increased to 3 mg/kg TID after 3 days)
8
122.9
64
7.8
21.5
 
133
16
14
 
 
213
 
Slight clinical improvement
9
65
37
12.7
22.6
 
156
 
 
165
 
 
 
Methylprednisolone (1 mg/kg BID) Marked clinical improvement Extubated day 9 Tranfusion
12
98.3
67
13.2
19.6
 
607
32
21
288
 
574
 
Echocardiogram: diffuse enlargement of the entire coronary artery system Infliximab 5 mg/kg ×1 Methylprednisolone increased (4 mg/kg TID)
16
1.6
25
11.3
12.9
 
963
27
28
201
239
700
108
Methylprednisolone decreased (2 mg/kg TID)
20
0.3
5
13
20.9
 
972
 
 
269
212
754
134
Methylprednisolone decreased (2 mg/kg Daily)
27 <0.2 8 11.3 16.7   427     293   406 58 Anakinra decreased (4 mg/kg BID) Methylprednisolone stopped Prednisolone started 1.5 mg/kg Daily (tapered over 10 days)

CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; Hb: hemoglobin; WBC: white blood count; PLTs: platelets; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gamma-glutamyl transpeptidase; IVIG: intravenous immunoglobulin treatment.